Thomas Kyllo
Dominic Allocco1
Jeffrey D. Erickson
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health-New Orleans, New Orleans, LA, United States
- 2Department of Pharmacology, School of Medicine, University of California-Davis, Davis, CA, United States
by Kyllo T, Allocco D, Hei LV, Wulff H and Erickson JD (2024). Front. Pharmacol. 15:1466953. doi: 10.3389/fphar.2024.1466953
In the published article, the legend of Supplementary Figure S1 was mistakenly not included in the publication. The missing legend appears below:
“SUPPLEMENTARY FIGURE S1 Riluzole attenuates neural degeneration in the mediodorsal thalamus caused by KA-induced SE. Riluzole-treated rats showed less FJC labeling (green) than the KA group in the mediodorsal thalamus at 7 days (top row) and 14 days (bottom row). *Indicates the 3rd ventricle. Low power (200x) and high power (400x) was captured using an exposure time of 400 ms. Scale bar = 200 μM for low power and 50 μM for high power.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: acute neural injury, kainic acid, neuroprotection, neuroinflammatory response, microglia and astrocytes, epileptogenesis, antiepileptogenic drug
Citation: Kyllo T, Allocco D, Vande Hei L, Wulff H and Erickson JD (2025) Corrigendum: Riluzole attenuates acute neural injury and reactive gliosis, hippocampal-dependent cognitive impairments and spontaneous recurrent generalized seizures in a rat model of temporal lobe epilepsy. Front. Pharmacol. 16:1592653. doi: 10.3389/fphar.2025.1592653
Received: 12 March 2025; Accepted: 18 March 2025;
Published: 31 March 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Kyllo, Allocco, Vande Hei, Wulff and Erickson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jeffrey D. Erickson, amVyaWNrQGxzdWhzYy5lZHU=